Despite the widespread use of cannabis in treating many conditions, pharmaceutical companies are still firmly opposed to legalizing the plant. Their opposition is largely due to the fact that it threatens their business. While the pharmaceutical industry creates medications for human healing, they have an egregious interest in greasing their own palms. That’s why Big Pharma is attempting to block all states from legalizing medical marijuana.
Until recently, the pharmaceutical industry fought medical marijuana reform in the U.S. Congress. Now, though, it has been working to push the issue. This year, Michigan voters approved a medicinal cannabis program, and lawmakers are exploring the possibility of doing so. But the state remains a total prohibition. The federal government has been slow to liberalize marijuana laws. But now, the situation is beginning to look different.
In 2012, a typical physician in a medical marijuana state prescribed 1,826 fewer doses of painkillers than he did a decade earlier. That’s a significant decline. And it’s an important reason why pharmaceutical companies are fighting marijuana reform. The pharma industry has long funded anti-pot academics and groups. They’ve also lobbied federal agencies to prevent cannabis liberalization.
If legalization is successful in Colorado, the Republicans would lose their ability to pass a constitutional amendment that would make cannabis recreational. But a vote is not likely, and Vice President Mike Pence has the power to break a tie. So it’s unlikely that the Republican Party could win a majority of seats in the House. If they lose a few seats, the bill would fail. The Democrats could introduce the legislation themselves and pass it, but this may be a long and difficult process.
A study by the ACLU found that the average medical marijuana physician in a medical marijuana state prescribed 1,826 fewer doses of painkillers in a year. The reduction in painkiller prescriptions buying weed seeds online usa is likely to worry the pharmaceutical industry. They’ve been fighting pot reform for decades, funding anti-pot academics and groups, and lobbying federal agencies to prevent its liberalization.
Despite the negative effects of legalization, there is no evidence that marijuana has a negative impact on human health. The majority of Americans support legalization, but pharmaceutical companies have a strong interest in blocking it. For instance, a law that allows medical marijuana in medical settings could make it less dangerous for patients. In contrast, a law allowing the use of cannabis in public places will cause fewer drug-related deaths.
Although marijuana has long enjoyed public support, pharma companies are still largely opposed to its use. Insys Therapeutics, for example, made the largest personal campaign donation to opponents of a medical marijuana initiative in Arizona. The company’s synthetic version of THC, the magic sauce of cannabis, is called Syndros. Its efforts to prevent the legalization of cannabis are detrimental to the health of the state, the economy, and the health of citizens.
The pharmaceutical industry has long fought against marijuana reform. The companies fund anti-pot academics and funnel their money to anti-pot organizations. They also lobby the federal government against marijuana, and lobby against it. A reschedule for marijuana has proven to be a great benefit for both states, as it will lower the cost of prescriptions. Another example is the increase in opioid use in medical states.
Insys has also been a key opponent of legal marijuana. The company financed anti-pot academics and groups that fought legal marijuana. It has lobbied federal agencies against the cannabis industry. The pharmaceutical industry is likely to have a strong stake in the outcome of legalization. Its resurgence has come as a result of the federal government’s failure to regulate the plant.